BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37164791)

  • 1. Umbilical lichen planus induced by nivolumab.
    Martos-Cabrera L; Lladó I; Fernández-Rico P; Butrón-Bris B; Rodríguez-Jiménez P
    An Bras Dermatol; 2023; 98(5):712-714. PubMed ID: 37164791
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple erosive lichen planus preceded by solitary lichen planus after combination therapy with nivolumab and radiation.
    Komori T; Honda T; Irie H; Otsuka A; Kabashima K
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):e382-e384. PubMed ID: 28295693
    [No Abstract]   [Full Text] [Related]  

  • 3. Linear bullous lichen planus associated with nivolumab.
    Biolo G; Caroppo F; Salmaso R; Alaibac M
    Clin Exp Dermatol; 2019 Jan; 44(1):67-68. PubMed ID: 29920744
    [No Abstract]   [Full Text] [Related]  

  • 4. Bullous lichen planus and anti-programmed cell death-1 therapy: Case report and literature review.
    de Lorenzi C; André R; Vuilleumier A; Kaya G; Abosaleh M
    Ann Dermatol Venereol; 2020 Mar; 147(3):221-227. PubMed ID: 31982173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal Lichen Planus Mimicking Mucosal Lesions in Stevens-Johnson Syndrome after Nivolumab Therapy.
    Miyagawa F; Nakajima A; Ohyama SI; Aoki Y; Nishikawa M; Nakamura Y; Hashimoto T; Asada H
    Acta Derm Venereol; 2019 Jun; 99(7):687-688. PubMed ID: 30938822
    [No Abstract]   [Full Text] [Related]  

  • 6. Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab.
    Sato Y; Fujimura T; Mizuashi M; Aiba S
    J Dermatol; 2019 Oct; 46(10):e374-e375. PubMed ID: 31062404
    [No Abstract]   [Full Text] [Related]  

  • 7. Nivolumab-induced lichen planus pemphigoides.
    Strickley JD; Vence LM; Burton SK; Callen JP
    Cutis; 2019 Apr; 103(4):224-226. PubMed ID: 31116807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nivolumab-induced lichen planus.
    Yilmaz M; Mese SG; Celik U
    J Oncol Pharm Pract; 2020 Apr; 26(3):758-760. PubMed ID: 31382865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated erythema with intense and selective inflammation of sweat gland and lichenoid drug eruption during nivolumab therapy.
    Matsumoto Y; Kadono T; Matsuoka M; Kawakami T; Furuya N; Doi M; Hoshikawa M; Soma Y
    J Dermatol; 2018 Feb; 45(2):e33-e34. PubMed ID: 28984022
    [No Abstract]   [Full Text] [Related]  

  • 10. Nivolumab-related lichen planus of the lip in a patient with head and neck cancer.
    Economopoulou P; Nicolatou-Galitis O; Kotsantis I; Psyrri A
    Oral Oncol; 2020 May; 104():104623. PubMed ID: 32144002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma.
    Denny J; Chong H; Akhras V
    Clin Exp Dermatol; 2018 Apr; 43(3):354-356. PubMed ID: 29222829
    [No Abstract]   [Full Text] [Related]  

  • 12. Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab.
    Shah RR; Bhate C; Hernandez A; Ho CH
    Dermatol Ther; 2022 May; 35(5):e15432. PubMed ID: 35266258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of severe nivolumab-induced lichen planus pemphigoides in a child with metastatic spitzoid melanoma.
    Mueller KA; Cordisco MR; Scott GA; Plovanich ME
    Pediatr Dermatol; 2023 Jan; 40(1):154-156. PubMed ID: 35882548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.
    Andrés-Lencina JJ; Burillo-Martínez S; Aragón-Miguel R; Calleja-Algarra A; Rodríguez-Peralto JL; Ortiz-Romero PL; Gargallo-Moneva V
    Australas J Dermatol; 2018 Nov; 59(4):e302-e304. PubMed ID: 29797309
    [No Abstract]   [Full Text] [Related]  

  • 15. Genital lichen sclerosus after nivolumab.
    Miraglia E; Soda G; Giustini S
    Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342187
    [No Abstract]   [Full Text] [Related]  

  • 16. Erosive Lichen Planus on the Extremities During Combination Therapy with Nivolumab and Radiation: A Second Case Report.
    Katsuo K; Honda T; Komori T; Kaku Y; Kabashima K
    Acta Derm Venereol; 2020 Mar; 100(6):adv00100. PubMed ID: 32176308
    [No Abstract]   [Full Text] [Related]  

  • 17. Nivolumab PD-1 inhibitor immunotherapy associated with vulvar, perineal and perianal lichen sclerosus.
    Wernham AGH; Shah F; Velangi S
    Clin Exp Dermatol; 2019 Mar; 44(2):e22-e23. PubMed ID: 30430637
    [No Abstract]   [Full Text] [Related]  

  • 18. Pembrolizumab-induced pseudoepitheliomatous eruption consistent with hypertrophic lichen planus.
    Coscarart A; Martel J; Lee MP; Wang AR
    J Cutan Pathol; 2020 Mar; 47(3):275-279. PubMed ID: 31589773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized Lichen Nitidus Following Anti-PD-1 Antibody Treatment.
    Cho M; Nonomura Y; Kaku Y; Dainichi T; Otsuka A; Kabashima K
    JAMA Dermatol; 2018 Mar; 154(3):367-369. PubMed ID: 29344609
    [No Abstract]   [Full Text] [Related]  

  • 20. Ulcerated Lichen Planus after Adjuvant Use of Programmed Cell Death-1-Inhibitor: A Case Report and Systematic Review of the Literature.
    Niesert AC; Guertler A; Schutti O; Engels L; Flaig M; French LE; Schlaak M; Reinholz M
    Acta Derm Venereol; 2021 Jun; 101(6):adv00472. PubMed ID: 34043014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.